Skip to Content

Join the 'Elepsia XR' group to help and get support from people like you.

Elepsia XR News

Study Sheds Light on Safety of Driving With Epilepsy

Posted 6 days ago by Drugs.com

SUNDAY, Dec. 4, 2016 – People with epilepsy who experienced longer seizures during a simulated driving test may face an increased risk for crashes while on the road, a new study suggests. About 75 percent of people with epilepsy use medication to control their seizures and are able to drive. The remainder of patients typically keep a journal of seizures, noting how long they last, and doctors use that information to determine whether patients can drive safely, the study authors explained. The new study included 16 people with epilepsy who used a driving simulator for between one to 10 hours, most for an average of three to four hours. In total, the patients had 20 seizures, seven of which resulted in "crashes." The longer the seizure, the greater the chance of a "crash." Seizures lasted an average of 75 seconds among patients who crashed and 30 seconds among those who didn't crash. The ... Read more

Related support groups: Seizures, Topamax, Epilepsy, Keppra, Topiramate, Tegretol, Dilantin, Qsymia, Seizure Prevention, Carbamazepine, Levetiracetam, Phenytoin, Tegretol XR, Seizure Prophylaxis, Valproic Acid, Carbatrol, Keppra XR, Epitol, Phentermine/topiramate, Status Epilepticus

Newer Epilepsy Drugs May Be Safer During Pregnancy

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don't run the risk of harming their infant's mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. "The treatment of epilepsy in women who are considering a pregnancy or are pregnant involves optimizing the health of the mother as well as keeping the risk to the fetus as low as possible," said lead researcher Rebecca Bromley, a research fellow at the Institute for Human Development at the University of Manchester. In the study, children exposed to levetiracetam (Keppra) or topiramate (Topamax) in the womb did not differ from children not exposed to these drugs. And they had better outcomes than the children exposed to valproate ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Seizures, Topamax, Epilepsy, Keppra, Topiramate, Qsymia, Seizure Prevention, Postcoital Contraception, Levetiracetam, Seizure Prophylaxis, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Keppra XR, Phentermine/topiramate, Status Epilepticus, West Syndrome, Lennox-Gastaut Syndrome, Topamax Sprinkle

FDA Approves First Pill Made by 3D Printing

Posted 4 Aug 2015 by Drugs.com

TUESDAY, Aug. 4, 2015 – The age of 3D printing has come to the drug industry, with the U.S. Food and Drug Administration on Monday approving the first pill made with the technology. The agency approved the prescription drug Spritam (levetiracetam) as a 3D-printed pill, to be taken with other medicines for seizures in certain children and adults with epilepsy. According to a news release from Ohio-based Aprecia Pharmaceuticals, the drug is made using a 3D printing method called ZipDose Technology, which produces a porous pill that rapidly disintegrates with a sip of liquid. 3D printing has already been used to make medical devices, but Spritam is the first 3D-printed drug to be approved for sale in the United States. It is expected to be available early next year. Experts say 3D printing of pills could usher in an era where drugs can be custom-ordered, based on specific patient needs, ... Read more

Related support groups: Seizures, Keppra, Seizure Prevention, Levetiracetam, Seizure Prophylaxis, Keppra XR, Spritam, Elepsia XR

Ask a Question

Further Information

Related Condition Support Groups

Seizures, Epilepsy

Elepsia XR Patient Information at Drugs.com